Golden gelatinous sorghum (GGS) is rich in phytochemicals and anti-oxidants. We investigated the toxicity and anti-inflammatory properties of a GGS extract. We observed no toxic effects after a daily dose of up to 5000 mg/kg body weight of the GGS extract administered orally to rats for 14 d. The exposure of mice ears to 12-O-tetradecanoylphorbol-13-acetate (TPA) caused a marked increase in ear thickness, which was significantly inhibited by treating with the GGS extract; this inhibition of inflammatory response was clearly confirmed by a histological analysis. The TPAinduced mice ear edema model, indicated that treating with the GGS extract inhibited the expression levels of such inflammatory mediators as cyclooxygenase-2 and inducible nitric oxide synthase. The nitric oxide level in lipopolysaccharide (LPS)-induced Raw264.7 cells in vitro was lower in the GGS extract-treated group than in the LPS-only treated group. These results suggest that sorghum would be a safe, nontoxic product, and that the GGS extract possessed significant anti-inflammatory activity.
reported to have some therapeutic benefits, including cardioprotective, anti-inflammatory, anticancer, and hypoglycemic properties. [1] [2] [3] Inflammation is one of the most crucial aspects of the host defense against invading pathogens, chemical damage, physical damage, and radiation. Various studies have suggested that plant materials containing compounds rich in anthocyanins possess anti-inflammatory activities. 4) There have been many reports of investigations into the properties of sorghum bicolor, but only a few studies have been made on the therapeutic effects and toxicological assessments of golden gelatinous sorghum (GGS). Since traditional medicinal plants have been used indiscriminately in the past, without any notice of their possible harmful effects, the World Health Organization has recommended that the toxicity and side effects of such plants should be scientifically investigated. 5) We investigated in this study the acute (14-d) toxicity, and evaluated the anti-inflammatory activity of a GGS extract toward SD rats.
Materials and Methods
Preparation of the golden gelatinous sorghum bran extract. The golden gelatinous sorghum (GGS) extract used in this study was obtained from the National Institute of Crop Science and Dept. of Food Science and Technology (Chungbuk Natl. Univ., Korea). Fresh GGS bran was dried in a dark well-ventilated place. A 10-g of the air-dried and milled GGS bran was extracted three times with 500 mL of 80% ethanol at 25 C and 150 rpm under reflux. The ethanol extract of GGS was passed through 3 MM filter paper (Whatman International, England) and concentrated at 40 C with an EYELA N-11 rotary evaporator (Tokyo, Japan). The extract was further fractionated with chloroform and ethyl acetate, before the solvent was removed by using a rotary evaporator. Approximately 7.2 g of GGS extracted with 80% ethanol (GE) was fractionated with 100 mL of ethyl acetate or chloroform in an Eyela Model MMS-300 shaker (Tokyo Rikakikai, Tokyo, Japan) at room temperature for 24 h. The extract was subsequently passed through Whatman 3 MM filter paper, and the filtrate was evaporated at 40 C to remove the solvent. The extracted yields of GGS were as follows: GE (80% ethanol extraction of GGS), 6.5%; Ea-GGS (ethyl acetate fractionation of GE), 4.78%; Ch-GGS (chloroform fractionation of GE), 1.53%.
Animals. Six-to seven-week-old ICR male mice and SpragueDawley (SD) male and female rats were purchased from a commercial animal breeder (Orient Bio, Seongnam, Gyeongi-do, Korea). Twentyy To whom correspondence should be addressed. Tel: +82-43-261-3446; Fax: +82-43-271-3246; E-mail: kimdj@cbnu.ac.kr Abbreviations: GGS, golden gelatinous sorghum; LPS, lipopolysaccharide; TPA, 12-O-tetradecanoylphorbol-13-acetate; COX-2, cyclooxygenase-2; iNOS, inducible nitric oxide synthase; GE, 80% ethanol extract of GGS; Ea-GGS, ethyl acetate fraction of GE; Ch-GGS, chloroform fraction of GE; DMSO, dimethyl sulfoxide; NED, N-(1-naphthyl)ethylenediamine dihydrochloride four male mice and one-hundred rats (50 males and 50 females) were acclimatized for 1 week in an environmentally controlled room at a temperature of 20 AE 2 C, relative humidity of 50 AE 20%, and a 12-h light/dark cycle; they were provided with a commercial standard diet and water ad libitum. All care and handling of the animals was performed according to the Guide for the Care and Use of Laboratory Animals of Chungbuk National University, Korea (CBNUA-347-11-01 and CBNUA-356-11-01).
Acute toxicity test on the rats. Each of the five test groups, including a control group, was composed of 10 SD rats. GE (the 80% ethanol extract of GGS) was orally administered at doses of 625, 1250, 2500, and 5000 mg/kg of body weight in 10 mL of a 0.5% carboxy methyl cellulose (CMC) solution, while 10 mL/kg of body weight of a 0.5% CMC solution was administered to the control group. Treatment was administered daily for 14 consecutive days by oral gavage at a volume of 10 mL/kg of body weight. The animals were observed 10, 30, 60, and 90 min, and 24 h after administering the treatment, until the end of the 14-d investigation, to assess the number of deaths and possible toxicological symptoms. The rats were sacrificed after 15-d, and the animals were autopsied and histological and blood analyses were conducted.
Hematological studies on the rats. The blood samples collected from the sacrificed rats were analyzed for the red blood cell (RBC) count, hemoglobin (Hb), hematocrit (Hct), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), mean corpuscular volume (MCV), white blood cell count, differential white blood cell count (neutrophils, lymphocytes, monocytes, eosinophils, and basophils) and platelet count. Hematological analyses were performed at the Laboratory for Animal Research Center of Chungbuk National University.
Serum biochemical studies on the rats. The blood samples for biochemical analyses were allowed to clot at 4 C and centrifuged at 3000 rpm (MX-300 microcentrifuge, Tomy, Tokyo, Japan) for 20 min. The serum and plasma was collected and analyzed for the following biochemical parameters: the albumin, glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), alkaline phosphates (ALP), creatinin, total protein, albumin, blood urea nitrogen (BUN), chloride, sodium, potassium, and calcium levels.
Organ to body weight ratio in the rats. The heart, liver, lungs, kidney, spleen, testes (male), and ovaries (female) were removed after sacrifice, and the absolute and relative organ weight (organ to body weight ratio) were calculated as follows:
Relative organ weight ¼ (weight of removed organ/body weight of rat on the day of sacrifice) Â 100
Histopathology of the rats. The liver, kidney, spleen, heart, and lung were also macroscopically examined. Samples of these organs were fixed in 10% buffered formalin and embedded in paraffin. Sections of 5-mm thickness were prepared and stained with hematoxylin and eosin (H&E), and examined under a light microscope.
12-O-Tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in the mice. Ear edema was induced in the mice (n ¼ 4) by topical application of TPA, as previously described, but with a slight modification. 6) Briefly, 20 mL of a TPA solution (100 mg/mL of TPA in acetone) or acetone was topically applied to the inner and outer surfaces of the ears. The GGS extracts (GE, the 80% ethanol extract of GGS; Ea-GGS, the ethyl acetate fraction of GGSx; and Ch-GGS, the chloroform fraction of GGSx) was dissolved in saline, and applied to the surface of the ears after the TPA treatment. To evaluate the antiinflammatory effects of the GGS extracts on TPA-induced ear edema in mice, we used visual observation, digital calipers, and imaging software (eXcope X3 Ver.5.0.1, DIXI Optics, Daejeon, Korea). The mice were sacrificed for the biochemical analyses, and ear biopsies obtained with a punch (4 mm diameter). The ear biopsies were frozen in liquid nitrogen and stored at À80 C until being used.
Cell culture and GGS extract treatment. The Raw264.7 murine macrophage cell line was obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). The Raw264.7 cells were cultured in plastic dishes containing Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Rockville, MD, USA) supplemented with 10% heatinactivated fetal bovine serum (FBS; Gibco BRL, Rockville, MD, USA), 100 U/mL of penicillin, and 100 mg/mL of streptomycin at 37 C in a CO 2 incubator (5% CO 2 , in air). Each GGS extract, dissolved in DMSO, was added to the cultured Raw264.7 cells with or without LPS (1 mg/mL) for 18 h. The final concentration of DMSO was adjusted to less than 0.1% for all treatments.
Cell viability assay. Cell viability was measured by using a standard WST assay. Raw264.7 cells were seeded in 96-well plates at 1 Â 10 4 cells/well for 24 h. The cells were then incubated with the 80% ethanol extract (GE) and fractionated GE with ethyl acetate and chloroform (Ea-GGS and Ch-GGS) in the presence of LPS (1 mg/mL) at 37
C for 24 h (GE: 1, 2, 5, 10, 25, 50, 100, and 200 mg/mL, Ea-GGS and Ch-GGS: 0.5, 1, 2, 5, 10, 20, 30, and 40 mg/mL). After incubating for 24 h, the each cell supernatant was removed, 10 mL/well of the WST-1 cell proliferation reagent (Roche Diagnotics, Mannheim, Germany) was added, and the cells were incubated for 2 h. After the absorbance had been measured with an EL-808 ELISA microplate reader (BIO-TEK Instruments, Winooski, VT, USA) at 490 nm, the cell viability was calculated as:
Cell viability ratio ¼ (absorbance of treated cells/absorbance of non-treated cells) Â 100
Measurement of nitric oxide (NO). NO production was indirectly assessed by measuring the nitrite levels in the cultured media by a colorimetric method based on the Griess reaction. 7, 8) Raw264.7 cells were incubated with the 80% ethanol extract (GE) and GE fractionated with ethyl acetate and chloroform (Ea-GGS and Ch-GGS) in the presence of LPS (1 mg/mL) at 37 C for 24 h (GE: 1, 2, 5, 10, 25, 50, 100, and 200 mg/mL; Ea-GGS and Ch-GGS: 0.5, 1, 2, 5, 10, 20, 30, and 40 mg/mL). The cells were then dispensed into 96-well plates, and 50 mL of each supernatant was mixed with an equivalent volume of Griess reagent (1% sulfanilamide, 0.1% naphthyl ethylenediamine dihydrochloride and 5% phosphoric acid) and incubated at room temperature for 10 min. The concentration of nitrite was measured by assessing absorbance at 540 nm with a Micro-Reader (BIO-TEK Instruments Inc.), and comparing against a sodium nitrite-generated standard curve.
Western blotting. Harvested Raw264.7 cells and ear tissues were lysed with Pro-PrepÔ (iNtRON Biotechnology, Seongnam, Gyeonggido, Korea) and incubated at 4 C for 2 h. The extracts were then centrifuged at Â13000 g and 4 C for 15 min to remove the insoluble material, and each supernatant was collected; a Bradford assay was applied to quantify protein, 9) using a protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA), and 30 mg of total protein was resolved by SDS-PAGE as previously described. 10) The proteins were then transferred to PVDF membranes. After blocking with 10% skim milk, the membranes were incubated with goat polyclonal anticyclooxygenase (COX)-2, or inducible nitric oxide synthase (iNOS) antibodies (Santa Cruz Biotechnology), and then with HRP-linked antigoat IgG, before detecting by using the LuminataÔ HRP chemiluminescence detection reagent (Millipore, Billerica, MA, USA). The optical density of the bands on the blots was evaluated by using the Multi Gauge program (Fujifilm, Minato, Tokyo, Japan).
Histopathological examination of the mice ears. Mice ears were fixed in 10% formalin. After embedding in paraffin, 5-mm sections were stained with H&E and Masson's trichrome stain, and then observed by light microscopy (CX21 Binocular Microscope, Olympus, Hicksville, NY, USA).
Statistical analysis. The measured data are expressed as the mean AE standard deviation (SD). Groups were compared by using one-way ANOVA and subsequent post-hoc Bonferroni test for multiple-group comparisons. Differences were considered statistically significant with p-values of <0.05.
Results

General observations
Doses of 625, 1250, 2500, and 5000 mg/kg did not cause death or any toxic signs in the treated male and female rats. All mice appeared normal throughout the study and survived until the end of the 14-d experimental period.
The animals did not show any changes in general behavior or other physiological activities.
Body weight and relative organ weights
Although the absolute weight of each rat increased during the experimental period, no significant differences in the body weight gain were recorded between the treated rats and the respective control groups at any time-point. The initial weights of the male and female rats used were 265:86 AE 3:00 g and 202:59 AE 6:16 g, and the respective final weights were 368:96 AE 2:72 g and 239:10 AE 3:10 g. The relative weights of the internal organs of both male and female rats in the treatment groups were not statistically different from those of the control group (Table 1) .
Hematological examination
The daily administration of GGS for 14 d did not cause any significant change in the RBC, Hb, Hct, MCV, platelet, monocyte, or basophil count at any dosage in either the male or female rats (Table 2 ). However, there was a significant decrease in MCH of the female rats receiving GE at doses of 1250, 2500, and 5000 mg/kg (p < 0:05), compared to the control group. However, the mild change in MCH level of the female rats treated with GE suggested variation according to the sexual cycle. The WBC and neutrophil levels were significantly higher in both the male and female rats receiving GE at a dose of 625 mg/kg than those in the control group (p < 0:05), but not in those receiving other doses of the extract (Table 2 ). Lymphocytes and monocytes were significantly affected in the male rats, but did not increase or decreased in a dose-dependent manner.
Biochemical and coagulation assessment After 14 d of treatment with GE, there were no significant changes in the serum and plasma levels of sodium, chloride, potassium, calcium, albumin, creatinin, total protein, BUN, ALP, GOT, and GPT among the treatment groups, or between the control and treatment groups ( Table 3 ). The results of such coagulation tests, as the activated partial thromboplastin time (APTT), prothrombin time, and fibrinogen were not significantly different from the control values (Table 4) .
Histopathological examination
The light microscopic examination of the liver, kidney, spleen, lung, and heart obtained from the rats after 14 d of administrating a GGS extract showed a normal cell structure and formation, comparable to that of the control, and no histological damage was apparent in the H&E-stained sections (Fig. 1) .
Cell viability examination
The cell viability ratio in Raw264.7 cells treated with LPS was not significantly affected by adding any of the GGS extracts. The cell viability tended to decrease slightly with treatment in the highest concentration when compared with treatment by LPS alone (200 mg/mL of GE, 89:40 AE 2:05%; 40 mg/mL of Ea-GGS, 93:92 AE 8:60%; 40 mg/mL of Ch-GGS, 85:41 AE 0:36%) (Fig. 2) .
Nitric oxide (NO) quantification
The NO level in Raw264.7 cells treated with LPS, was decreased with the addition of a GGS extract. NO levels was significantly decreased with GE, Ea-GGS, and Ch-GGS when compared to the treatment with LPS alone (Fig. 3) .
Assessment of TPA-induced ear edema in the mice
The thickness of the mice ears was significantly decreased in the GE, Ea-GGS, and Ch-GGS treatment groups when compared to the control group (Figs. 4 and 5, and Table 5 ). In particular, the thickness of the dermis was reduced in the extracts-treated groups when compared to the TPA-only treatment control group (TPA: 512:76 AE 36:20; GGS 5: 155:44 AE 29:07; GGS 10: Table 5 ).
Western blot analysis in vivo Each GGS extract suppressed inflammation-related proteins with the TPA-induced ear edema when compared to the TPA-only-treated control group and the untreated normal group. The in vivo expression levels of iNOS and COX-2 were significantly weakened by the treatment with GE, Ea-GGS, and Ch-GGS as measured by a Western blot analysis. The optical density ratios of the analyzed COX-2 proteins were as follows: normal, Values are expressed as means AE SD. GE, golden gelatinous sorghum bran extract with an 80% ethanol; BUN, blood urea nitrogen; ALP, alkaline phosphatase; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase. (Fig. 6 ).
Discussion
Sorghum is a principal cereal crop in many countries, together with wheat, rice, corn and barley. It has been regarded as a traditional medical plant in Asia and Africa throughout its history. 11, 12) A diet rich in phytochemicals is beneficial to human health because of their significant antioxidative properties. 13, 14) Sorghum is rich in those phytochemicals known to significantly affect human health such as tannins, phenolic acids, and anthocyanins which are secondary plant metabolites or integral cellular components. 11, 15) Recent studies have proven that sorghum had antimutagenic, anti-cancer, and cholesterol-lowering effects, decreased cardiovascular disease, and had particularly high anti-oxidative activity. 16, 17) It is traditionally used for treating edema, inflammation, diarrhea, cardiovascular disease, obesity, hypertension, and diabetes. [1] [2] [3] 18, 19) It is commonly consumed as a health and diet food, but its safety for intake had not previously been evaluated. In this study, we therefore investigated the toxicity and anti-inflammatory properties of golden gelatinous sorghum.
We used a high dose of GE, viz., up to 5000 mg/kg of body weight, expecting to induce some observable toxic effects on the SD rats. We found that GE did not induce any mortality or abnormal symptoms, even at the highest dose, suggesting that its LD 50 value was higher than Values are expressed as means AE SD. GE, golden gelatinous sorghum bran extract with an 80% ethanol; APTT, activated partial thromboplastin time; PT, prothrombin time. Fig. 1 . Histological Examination of the Rats. The GE (golden gelatinous sorghum bran extract with 80% ethanol), administered orally at a daily dose of 625, 1250, 2500, or 5000 mg/kg of body weight for 14 d, did not cause any significant changes. Males (A, B, and C), females (D, E, and F), liver (A and D), spleen (B and E), kidney (C and F), control group (1), 625 mg/kg of body weight in the GE treatment group (2), 1250 mg/kg body weight GE treatment group (3), 2500 mg/kg of body weight in the GE treatment group (4), 5000 mg/kg of body weight in the GE treatment group (5). 5000 mg/kg of body weight, and that it was a non-toxic and safe product in the acute toxicity study. We found that a repeated daily dose of the extract at 625, 1250, 2500, or 5000 mg/kg/10 mL body weight for 14 d did not produce any mortality or clinical signs of toxicity, further establishing the safety of the extract. The results of this study also show no significant difference in body weight between the sorghum-treated and control mice during the experimental period, although the body weight of both groups of rats increased with time. The increase in body weight during the study period also indicates that the intake of a GGS extract had no toxic effects. It is not uncommon for a herbal extract to result Twenty microliters of the TPA (12-O-tetradecanoylphorbol-13-acetate) solution (100 mg/mL of TPA in acetone) or acetone was topically applied to the inner and outer surfaces of the mouse ears. TPA treatment (B, C, D, E, and F); A, untreated control; B, only the 12-Otetradecanoylphorbol-13-acetate (100 mg/mL of TPA in acetone)-treated group; C, GE (golden gelatinous sorghum extraction with 80% ethanol) 5 mg/mLtreatment in TPA solution; D, GE (golden gelatinous sorghum extract with 80% ethanol) 10 mg/mL treatment in the TPA solution; E, Ea-GGS (GE extract fractionated with ethyl acetate) 1 mg/mL treatment in the TPA solution; F, Ch-GGS (GE extract fractionated with chloroform) 1 mg/mL treatment in the TPA solution.
in an increase in body weight of the experimental animals due to pharmacological effects related to the anti-oxidative activities of the extracts. 18, 20) The effect of the GGS intake on the hematological parameters in rats was to significantly decrease the MCH level in the GGS extract-treated female rats (p < 0:05) when compared to the control group (control, 25:90 AE 0:23; GE 1250 mg/kg of body weight, 24:73 AE 0:41; GE 2500 mg/kg of body weight, 25:00 AE 0:63; GE 5000 mg/kg of body weight, 24:32 AE 0:46). However, these results seemed to be a variation according to the sex cycle, rather than due to the toxicity of sorghum. Moreover, the daily oral administration of an extract for 14 d significantly increased the WBC count in both the male (control, 8:22 AE 1:49; GE 625 mg/kg of body weight, 8:36 AE 0:51), and female (control, 8:39 AE 2:62; GE 625 mg/kg of body weight, 8:60 AE 1:66) rats in the group treated with an extract at 625 mg/kg of body weight when compared with the control group. The increases in neutrophils, monocytes, and lymphocytes is assumed to indicate that the sorghum extract contained the optimum amounts of biologically active components that stimulated the leukopoietic system and boosted the immune system by increasing WBC. This result is assumed to be due to such known ingredients of the sorghum extract as flavonoids, tannins, anthocyanins, and phenols. Components such as flavonoids have been reported to have immunological and anti-oxidative The ear thickness in the GGS extract-treated group was significantly less than that in the TPA (12-O-tetradecanoylphorbol-13-acetate solution, 100 mg/mL of TPA in acetone)-only-treated group. TPA treatment (B, C, D, E, and F); A, untreated control; B, 12-O-tetradecanoylphorbol-13-acetate solution (100 mg/mL of TPA in acetone)-only-treated group; C, GE (golden gelatinous sorghum extract with 80% ethanol) 5 mg/mL treatment in the TPA solution; D, GE (golden gelatinous sorghum extract with 80% ethanol) 10 mg/mL treatment in the TPA solution; E, Ea-GGS (GE fractionated extract with ethyl acetate) 1 mg/mL treatment in TPA solution; F, Ch-GGS (GE fractionated extract with chloroform) 1 mg/mL treatment in the TPA solution; 1, H&E staining; 2, Masson's trichrome staining (red, epidermis; blue, dermis). -, 100 mM. 
ÃÃ
Values are expressed as means AE SD. Normal, untreated group; TPA, only 12-O-tetradecanoylphorbol-13-acetate solution (100 mg/mL of TPA in acetone)-treated group; GE 5, GE (golden gelatinous sorghum extract with 80% ethanol) 5 mg/mL treatment in TPA solution; GE 10, GE 10 mg/mL treatment in TPA solution; Ea-GGS 1, Ea-GGS (GE extract fractionated with ethyl acetate) 1 mg/mL treatment in TPA solution; Ch-GGS 1, Ch-GGS (GE extract fractionated with chloroform) 1 mg/mL treatment in TPA solution. y p < 0:05 compared to normal. Ã p < 0:05 and ÃÃ p < 0:01 compared to control (TPA only). Histological measurements were performed image analysis software (eXcope X3 Ver.5.0.1).
y p < 0:05 compared to normal. Ã p < 0:05 and ÃÃ p < 0:01 compared to control (TPA only).
activities. 1, 2) However, the GGS extract had no significant effect in the biochemical parameter and coagulation tests, as the standard error values were large.
Ear biopsies in the TPA-induced ear edema of mice treated with the GGS extracts weighed significantly less than the TPA-only-treated group (control). The ear thickness of the former mice was significantly less (p < 0:05) than that in the TPA-treated control mice; the thickness of the dermis layer, in particular, was significantly less than that of the control (TPA only, 512:76 AE 36:20 mm; GE 5, 155:44 AE 29:07 mm; GE 10, 128:82 AE 26:42 mm; Ea-GGS 1, 128:66 AE 8:06 mm; Ch-GGS 1, 128:90 AE 23:30 mm; p < 0:01). The Western blot analysis showed that the expression of COX-2 (TPA only vs. GE 5, GE 10, Ea-GGS 1, and Ch-GGS 1: 100% vs. 75.9, 57.90, 26.25, and 37.53%, respectively) and of iNOS (TPA only vs. GE 5, GE 10, Ea-GGS 1 and Ch-GGS 1: 100% vs. 37.68, 36.68, 13.76, and 8.87%, respectively) was significantly lower (p < 0:05) than that in the TPA-only treated group. These results suggest that some ingredients of GGS reduced the edema by inhibiting the expression of such inflammatory mediators as COX-2 and iNOS. NO production is controlled by NOS, which includes iNOS, eNOS, and nNOS. Moreover, iNOS is highly expressed in macrophages; its activation leads to organ destruction in some inflammatory and autoimmune diseases.
21) COX-2 is highly induced in response to pro-inflammatory stimuli, cytokines, and mitogens, resulting in an exaggerated prostaglandin release. [22] [23] [24] In conclusion, the results of this study suggest sorghum to be a safe, nontoxic product, and that the sorghum extract possessed significant anti-inflammatory activity in the animal experiments. The consumption of GGS may therefore be an effective strategy for protecting against inflammation. Further studies are needed to define the mechanism underlying the protective effects of GGS more fully.
A B A, optical density of COX-2 (cyclooxygenase-2); B, opotical density of iNOS (inducible nitric oxide synthase). Normal, untreated control; TPA, only 12-O-tetradecanoylphorbol-13-acetate solution (100 mg/mL of TPA in acetone)-treated group; GGS 5, GE (golden gelatinous sorghum extract with 80% ethanol) 5 mg/mL treatment in the TPA solution; GGS 10, GE (golden gelatinous sorghum extract with 80% ethanol) 10 mg/mL treatment in the TPA solution; Ea-GGS 1, Ea-GGS (GE fractionated extract with ethyl acetate) 1 mg/mL treatment in TPA solution; Ch-GGS 1, Ch-GGS (GE fractionated extract with chloroform) 1 mg/mL treatment in the TPA solution.
y p < 0:05 compared to the untreated control.
Ã p < 0:05 compared to the TPA-only-treated control.
